A year ago, we were talking about a startup that had created a portable device that could monitor blood sugar and how Apple should buy it. Well, at present, the Japanese company in question, Quantum Operation Inc., is still free. And in the meantime, he presented his new smartwatch with a non-invasive blood glucose meter.
A blood glucose sensor in the form of a connected watch
Diabetes is a disease that affects hundreds of millions of people around the world, according to the WHO. Its incidence increased from 108 million people in 1980 to 422 million in 2014. In 2019, 1.5 million people died.
These numbers make non-invasive blood sugar testing the holy grail of all wearable clothing manufacturers. A way to measure blood sugar without the need for a needle stick. Well, Quantum Operation already had a laptop capable of doing this last year.
And this year, the Japanese startup delighted us with a smartwatch with a non-invasive glucose sensor at CES 2022. As can be seen in the video above, we have a prototype of the glucometer integrated into the Quantum Operation smartwatch. The user starts a blood glucose test with an app and then waits for the test to complete.
The proposal is complemented by a heart rate sensor and a blood oxygen sensor, from the Apple Watch Series 6. Although we are still waiting for a commercial product on the market under the name of this company, which could still take years.
A startup still free and without falling into the “clutches” of Apple
Last year, Quantum Operation had already made people talk about it with its quantifier bracelet capable of measuring blood sugar. And yet, it still has not fallen under the clutches of Apple, a company very inclined to poach this type of startups. One of those seen and not seen. Deal concluded for an amount of unknown millionaire. No other company picked it up, otherwise it would have disappeared from the CES map as well. The truth is, if at this point you are still independent, it could be for a number of reasons.
The first and most obvious is that Apple has already developed its own blood sugar technology for the Apple Watch. As has been said for a long time, we could see it as early as this year’s Apple Watch Series 8. In fact, we know that current Apple Watch sensors are already years away from the competition.
Another option is that the technology is not as precise as it is sold by Quantum Operation. That its commercial or large-scale viability is no closer than other alternative technologies. Making one or more prototypes is not the same as building millions of them in a short period of time. This would reduce the attractiveness of a large company as a buying target.
Everything indicates that a solution to the problem of punctures in diabetics could be closer than you think. Investing in these technologies portends a happy ending for millions of people, although we will probably have to wait a few more years.